Clydesdale Bank Invests $7.8M into Lab21 | GenomeWeb

NEW YORK (GenomeWeb News) – Clydesdale Bank has provided diagnostics firm Lab21 with £5 million ($7.8 million) to support the company's growth plans.

Lab21, based in Cambridge, UK, provides diagnostics products and services for companion diagnostics in personalized medicine, blood bank screening, and other clinical diagnostics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.